{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-343474","form_type":"8-K","ticker":"STIM","cik":"0001227636","company_name":"Neuronetics, Inc.","filed_at":"2026-08-11T12:05:08+00:00","discovered_at":"2026-08-11T12:10:07.150148+00:00","generated_at":"2026-08-11T12:10:46.583336+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Neuronetics Q2 revenue up 9.1% to $41.6M; EBITDA turns positive at $0.3M","bullets":["Q2 total revenue $41.6M, +9.1% YoY; Greenbrook $26.9M +16.8%, NeuroStar $14.7M -2.7%.","Net loss narrowed to $3.4M ($0.05/sh) from $10.1M; adjusted EBITDA $0.3M vs -$5.6M.","Gross margin up to 51.1% from 46.6%; operating expenses down 12% to $22.7M.","FY2026 guidance: revenue narrowed to $160-164M; gross margin raised to 48-50%; opex cut to $95-100M.","Nir Naor named EVP/CFO; Cory Anderson promoted EVP/GM Greenbrook; Rob Greene SVP Sales."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-343474","json":"https://secwatch.observer/filing/0001193125-26-343474.json","markdown":"https://secwatch.observer/filing/0001193125-26-343474.md","text":"https://secwatch.observer/filing/0001193125-26-343474.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1227636/000119312526343474/0001193125-26-343474-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1227636/000119312526343474/d78613d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-11T12:10:46.583336+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}